Serina Therapeutics Inc (SER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 702 | 448 | 584 | 731 | 615 |
| Receivables | 12 | N/A | 25 | 24 | 11 |
| TOTAL | $1,725 | $1,829 | $2,234 | $1,475 | $1,556 |
| Non-Current Assets | |||||
| Intangibles | 804 | 837 | 870 | 902 | 935 |
| Other Non-Current Assets | 50 | 50 | 50 | 50 | 50 |
| TOTAL | $854 | $887 | $920 | $952 | $985 |
| Total Assets | $2,579 | $2,716 | $3,154 | $2,427 | $2,541 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 751 | 1,166 | 841 | 995 | 1,398 |
| Other current liabilities | 8,334 | 8,933 | 8,126 | 5,603 | 3,873 |
| TOTAL | $9,085 | $10,099 | $8,967 | $6,598 | $5,271 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,756 | 4,209 | 6,063 | 5,807 | 5,565 |
| TOTAL | $6,756 | $4,208 | $6,062 | $5,807 | $5,564 |
| Total Liabilities | $15,841 | $14,307 | $15,029 | $12,405 | $10,835 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,078 | 1,078 | 1,078 | 1,077 | 1,077 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -111,072 | -108,454 | -105,748 | -103,590 | -101,635 |
| Other shareholders' equity | -44 | -44 | -43 | -42 | -42 |
| TOTAL | $-13,262 | $-11,591 | $-11,875 | $-9,978 | $-8,294 |
| Total Liabilities And Equity | $2,579 | $2,716 | $3,154 | $2,427 | $2,541 |